Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Everything we know about Mounjaro, new NHS weight loss jab
Weight-loss drug Mounjaro will help 'so many' people, say users
Weight-loss drug Mounjaro is set to be rolled out on the NHS in England from March. It is one of many weight-loss drugs that have become increasingly popular in recent years, and are sold privately by clinics and pharmacies.
What is Mounjaro? The new NHS weight loss jab with a 12-year wait
Warning it is ‘not a magic bullet’, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, said: ‘Weight loss drugs, such as tirzepatide, are an important tool in helping people lose weight while also reducing the risk of other serious long-term conditions such as diabetes, strokes and heart attacks.
Mounjaro, the ‘King Kong’ of weight loss jabs, will be available in Ireland early next year
A new drug dubbed the “King Kong” of weight-loss jabs will be available in Ireland early next year, it was confirmed yesterday. Mounjaro, a brand name for tirzepatide, can be used to treat obesity or type 2 diabetes.
NHS gets 12 years to roll out new weight-loss drug Mounjaro
A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the NHS drugs advisory body says. The National Institute for Health and Care Excellence (NICE) final draft guidance on Mounjaro has recommended it starts being given from March, alongside advice on diet and exercise.
Obese people ‘will have to wait’ for weight loss jab Mounjaro, NHS officials warn
However, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, warned that weight loss jabs “are not a magic bullet”.
Who can get new weight-loss jab Mounjaro on the NHS?
The rollout of the weight-loss drug to 3.4 million eligible patients could take up to 12 years, according to NICE.
How does weight loss drug Mounjaro work and why is it in such high demand?
Mounjaro, known as the “King Kong of weight loss drugs”, will be available to patients on the NHS, but this week it was announced the medication will be prioritised to people with the highest needs – with the rollout expected to extend over 12 years.
Weight loss drug Mounjaro will be available via the NHS for some people living with obesity
Weight loss jab tirzepatide – commonly sold under the brand name Mounjaro – is set to become available via the NHS for eligible patients in England. It could take up to 12 years for everyone who meets the criteria to actually receive it,
What is Mounjaro and how does it compare to other weight loss medications?
The new generation of weight-loss drugs were initially developed to treat diabetes and work by mimicking a hormone that regulates insulin levels and appetite. When celebrities started shedding pounds with private prescriptions for the diabetes drug Ozempic,
The Independent on MSN
2d
The ‘King Kong of weight-loss drugs’ – what is Mounjaro and who will be eligible for it?
We believe quality journalism should be available to everyone, paid for by those who can afford it.
Weight
-
loss
injection ...
16h
Could Eli Lilly Beat Rivals in the Billion-Dollar Weight Loss Drug Market in 2025? Evidence Is Piling Up, and Here's What It Says.
Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...
11h
‘King Kong’ of weight loss jabs set to hit Irish market as soon as next year
A NEW weight loss jabs dubbed the “King Kong” is set to hit the Irish market as soon as next year. Mounjaro can be used to ...
Science News
1d
How the weight loss drug tirzepatide is also helping heart failure patients
Data continue to show that tirzepatide, called Mounjaro for type 2 diabetes and Zepbound for weight loss, is safe and effective, but side effects remain.
3d
Zepbound leads to more weight loss than Wegovy, Eli Lilly says
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...
2d
Zepbound Leads to More Weight Loss Than Wegovy in Head-to-Head Clinical Trial
Drug manufacturer Eli Lilly says their drug Zepbound is more effective than Wegovy for long-term weight loss. Results from a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Eli Lilly and Company
Wegovy
Zepbound
Ozempic
NHS
Feedback